We are live on ! Find out more
TTOO

T2 Biosystems, Inc
TTOO

Delisted

TTOO was delisted on the 11th of February, 2025.

Back to rankings

53 hedge funds and large institutions have $24.5M invested in T2 Biosystems, Inc in 2020 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

143% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 7

100% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 7

68% more call options, than puts

Call options by funds: $611K | Put options by funds: $363K

29% more capital invested

Capital invested by funds: $19M → $24.5M (+$5.56M)

15% more funds holding

Funds holding: 46 → 53 (+7)

Holders
53
Holders Change
+7
Holders Change %
+15.22%
% of All Funds
1.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
17
Reduced
7
Closed
7
Calls
$611K
Puts
$363K
Net Calls
+$248K
Net Calls Change
-$87K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$897K
2
BlackRock
BlackRock
New York
+$838K
3
Osaic Holdings
Osaic Holdings
Arizona
+$838K
4
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$408K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$393K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$274K
2
Citadel Advisors
Citadel Advisors
Florida
-$185K
3
AIP
ARS Investment Partners
New York
-$133K
4
Wells Fargo
Wells Fargo
California
-$126K
5
GS
Gagnon Securities
New York
-$66.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
CA
26
Continuum Advisory
Idaho
$66K – – –
Charles Schwab
27
Charles Schwab
California
$65K – – –
Bank of New York Mellon
28
Bank of New York Mellon
New York
$58K – – –
Bank of America
29
Bank of America
North Carolina
$51K +$37.1K +5 +250%
FWM
30
Focused Wealth Management
New York
$50K – – –
EGM
31
Engineers Gate Manager
New York
$48K -$37.1K -5 -42%
UBS Group
32
UBS Group
Switzerland
$38K +$22.2K +3 +100%
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
$32K -$274K -37 -88%
WP
34
WealthPLAN Partners
Nebraska
$31K – – –
Victory Capital Management
35
Victory Capital Management
Texas
$31K +$7.41K +1 +25%
State Street
36
State Street
Massachusetts
$30K – – –
US Bancorp
37
US Bancorp
Minnesota
$23K – – –
CL
38
CIM LLC
New York
$22K +$22.2K +3 New
HR
39
Howe & Rusling
New York
$20K +$22.2K +3 New
CAI
40
Capital Advisors Inc
Oklahoma
$19K – – –
Creative Planning
41
Creative Planning
Kansas
$19K – – –
FGA
42
Fortis Group Advisors
New Jersey
$19K +$22.2K +3 New
JP Morgan Chase
43
JP Morgan Chase
New York
$19K +$22.2K +3 New
Morgan Stanley
44
Morgan Stanley
New York
$18K +$7.41K +1 +50%
Cambridge Investment Research Advisors
45
Cambridge Investment Research Advisors
Iowa
$16K -$7.41K -1 -33%
EWM
46
Empirical Wealth Management
Washington
$15K – – –
LNC
47
Lincoln National Corp
Pennsylvania
$14K +$14.8K +2 New
IA
48
IFP Advisors
Florida
$7K – – –
WEC
49
Winslow Evans & Crocker
Massachusetts
$7K – – –
PFO
50
Pathstone Family Office
New Jersey
$7K +$7.41K +1 New
1
2
3

TTOO Hedge Fund Activity: Q3 2020 in Review

53 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q3 2020, worth a combined $24.5M — up 29% from $19M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new TTOO positions and 7 closed out — a net gain of 7 holders — while 17 added to existing stakes and 7 trimmed.

The largest buyer was Vanguard Group, adding an estimated $897K. The largest seller was Susquehanna International Group, cutting an estimated $274K.

  • 53 institutional investors held T2 Biosystems, Inc (TTOO) as of Q3 2020, up from 46 in Q2 2020.
  • Funds reported $24.5M of T2 Biosystems, Inc stock for Q3 2020, up 29% quarter-over-quarter.
  • 14 funds opened new T2 Biosystems, Inc positions in Q3 2020 and 7 closed out, a net change of +7 holders.
  • The largest T2 Biosystems, Inc buyer in Q3 2020 was Vanguard Group, an estimated $897K added.
  • The largest T2 Biosystems, Inc seller in Q3 2020 was Susquehanna International Group, an estimated $274K sold.

Based on aggregated 13F filings for Q3 2020.